Overview
Related Diseases & Conditions
Summary
Prenatal care is a key component of a healthy pregnancy. Regular prenatal care helps to identify and treat complications and to promote healthy behaviors.Summary
Nausea and vomiting in pregnancy (NVP), commonly referred to as morning sickness, typically begins between the fourth and eighth week after the last menstrual period. It is characterized by nausea and vomiting that occurs more frequently during the morning hours, and typically resolves in the second trimester. NVP occurs in up to 50% to 80% of pregnant women.[1] Hyperemesis gravidarum is the most severe form of NVP and is characterized by persistent vomiting, volume depletion, ketosis, electrolyte disturbances, and weight loss.Summary
Pregnant and lactating women have an increased folate demand, which can result in folate deficiency. Folate deficiency during pregnancy is strongly associated with fetal neural tube defects, 70% of which can be prevented by increased folic acid supplementation.[2] [3] [4] Symptomatic inquiry should cover symptoms associated with anemia, including fatigue, palpitations, shortness of breath, dizziness, headaches, jaundice, loss of appetite, and weight loss.Summary
In pregnant women, iron deficiency anemia is defined as hemoglobin <110 g/L (11 g/dL).[5] Symptoms include fatigue, low energy levels, and dyspnea on exertion. Pregnancy increases demand for iron with a net loss of approximately 580 mg of iron during the gestation period, with the highest loss occurring in the third trimester.[6] [7] Iron deficiency during the first 2 trimesters is associated with an increase in preterm delivery and low birth-weight babies.[8]Summary
Defined as an involuntary, spontaneous loss of a pregnancy before 20-24 completed weeks (gestation varies, depending on country).[9] It is associated with unprovoked vaginal bleeding with or without suprapubic pain. Miscarriage occurs in up to one third of pregnancies.[10] [11] [12] [13] [14] Key risk factors include older parental age, uterine malformation, bacterial vaginosis, and thrombophilias. Serial serum beta hCG titers and a transvaginal ultrasound scan aid in diagnosis.Summary
More than one-half of women with recurrent miscarriage have unexplained or idiopathic recurrent miscarriage, where no cause or association can be identified.[15] [16] Increasing maternal age and number of previous miscarriages increase the risk of further miscarriages. Definitive associations of recurrent miscarriage include chromosomal abnormalities, antiphospholipid syndrome, certain structural uterine abnormalities such as cervical incompetence, and certain thrombophilias.Summary
A fertilized ovum implanting and maturing outside of the uterine endometrial cavity, with the most common site being the fallopian tube (97%), followed by the ovary (3.2%) and the abdomen (1.3%).[17] Classic symptoms and signs are pain, vaginal bleeding, and amenorrhea.[18] Global rates of ectopic pregnancy are 1.1% in the UK, 1.23% in the US, 1.49% in Norway, and 1.62% in Australia.[19] [20] [21] [22] Red flags suggesting possible rupture include unstable vital signs (orthostatic changes), blood in the vaginal vault, or signs of intraperitoneal bleeding (e.g., acute abdomen, shoulder pain, cervical motion tenderness). Risk increases with prior ectopic pregnancy, tubal surgery, history of sexually transmitted infections, smoking, in vitro fertilization, or if pregnant despite intrauterine device usage.Summary
Classified as placenta praevia if the placenta is directly covering the cervical os, or as low-lying placenta if the placental edge is <2 cm from the cervical os. Occurs in 0.3% to 0.5% of pregnancies worldwide.[23] [24][25] Symptomatic placenta previa typically presents as second or third trimester painless vaginal bleeding.[26] [27] [28] Risk factors include previous uterine scarring (most commonly due to prior cesarean section), advanced maternal age, smoking, previous multiple pregnancies/short interpregnancy intervals or miscarriages/induced abortions, prior placenta previa, infertility treatment, and illicit drug use.Summary
Hydatidiform moles are chromosomally abnormal pregnancies that have the potential to become malignant (gestational trophoblastic neoplasia). Gestational trophoblastic disease (GTD) includes tumors of fetal tissues, including hydatidiform moles, arising from placental trophoblasts. The most common presenting symptom is vaginal bleeding and patients typically present in the first trimester. Women with molar pregnancies are commonly at the extremes of reproductive life (younger than 20 years of age or over 35 years of age), and may relate a history of prior GTD.[29] [30]Summary
Early pregnancy causes of abdominal pain include ectopic pregnancy, miscarriage and ovarian hyperstimulation syndrome. Late pregnancy causes include preterm labor, chorioamnionitis, uterine rupture, placental abruption, HELLP syndrome, and acute fatty liver of pregnancy. Gynecologic causes include adnexal masses and fibroids. Other etiologies can be urologic (e.g., urinary tract infections [UTIs], acute pyelonephritis, nephrolithiasis, and hydronephrosis), gastrointestinal (e.g., appendicitis, cholecystitis, pancreatitis, and intestinal obstruction), trauma-related, and musculoskeletal.Summary
Defined by a blood pressure of ≥140/90 mmHg on two occasions (at least 4 hours apart) during pregnancy after 20 weeks gestation in a previously normotensive woman, without the presence of proteinuria (<300 mg in 24 hours) or other clinical features suggestive of preeclampsia (thrombocytopenia, impaired renal or kidney function, pulmonary edema, or new-onset headache).[31] [32] Hypertension is the most frequently identified medical problem during pregnancy. Women with gestational hypertension are usually asymptomatic. Risk factors include nulligravidity, black or Hispanic ethnicity, multiple pregnancies, obesity, and mothers who were born small for their gestational age. Gestational hypertension increases the risk of macrosomia, intrauterine growth restriction, stillbirth, cesarean delivery, and admission of the neonate to the intensive care unit. Coexistence of gestational diabetes mellitus further increases the risk.[33]Summary
Hyperglycemia in pregnancy that is below the diagnostic thresholds for diabetes mellitus.[34] [35] Develops during pregnancy and is usually diagnosed following assessment for risk factors followed by elevated plasma glucose levels on glucose tolerance testing. It is estimated that in 2021, 16.7% of pregnancies worldwide that resulted in live births were affected by some form of hyperglycemia.[36] Risk factors include advanced maternal age (>40 years), previous gestational diabetes mellitus, previous macrosomic baby, elevated BMI, polycystic ovarian syndrome, nonwhite ancestry, family history of type 2 diabetes mellitus, lack of exercise, and prior gestational diabetes mellitus.[37] [38] [39] [40] [41] [42] [43] [44] [45]Pregnancy can also be complicated by established type 1 or type 2 diabetes mellitus.Summary
An infection of the kidneys, bladder, or urethra. UTIs in pregnancy are considered to be complicated UTIs. Lifetime incidence of UTIs is 50% to 60% in adult women. Pregnant women should be screened for asymptomatic bacteriuria as it has been associated with higher rates of pyelonephritis, premature labor, and fetal mortality.[1]Summary
Inflammation of the vagina due to changes in the composition of the vaginal microenvironment from infection, irritants, or from hormonal deficiency (e.g., atrophic vaginitis). Bacterial vaginosis continues to be a leading cause of vaginitis; other common infectious causes include trichomoniasis and candidiasis. Vaginitis is the most common gynecological diagnosis in the primary care setting.[46] Common symptoms include discharge, pruritus, and dyspareunia. Bacterial vaginosis and trichomoniasis have been associated with preterm delivery, low birth weight, and premature rupture of membranes.[47] [48]Summary
A food-borne infection caused by a motile, nonspore-forming, gram-positive bacillus. Pregnant women are advised to avoid raw unwashed vegetables, raw or undercooked meat (poultry, beef, pork), leftover food, soft cheeses, and unpasteurized milk or its products.[49] [50] [51] [52] The pathogen has a predilection for neonates (ages <1 month), adults (especially >50 years), pregnant women (30% of all patients), and immunocompromised people (with HIV/AIDS, cancer, hematological malignancies, those undergoing corticosteroid treatment, or transplant recipients).[49] [53] [54] Pregnant women may have flu-like symptoms (lethargy, fever, arthralgias, myalgias, rigors, fatigue, diarrhea, vomiting, and abdominal pain).[50]Summary
Parasitic disease caused by the protozoan Toxoplasma gondii. Spreads through food or water contaminated with oocysts, infected meat, or contact with oocysts from feline feces. Transplacental transmission results only when a seronegative woman acquires toxoplasmosis during pregnancy. Primary infection during pregnancy is often asymptomatic in the mother, but can result in fetal death and severe congenital abnormalities (e.g., intellectual disability and blindness). National surveys in France have shown a decreasing T gondii seroprevalence among pregnant women, with models estimating a decrease in prevalence from 76% in 1980 to 27% in 2020.[55] Fetal infections in the third trimester are often asymptomatic at birth, but the majority of these congenitally infected children (up to 85%) develop retinitis, central nervous system problems (e.g., learning disabilities or seizures) or delayed growth months to years later.[56] Routine prenatal screening for T gondii is not performed in the US. However, in some countries (e.g., France) it is recommended.Summary
Cytomegalovirus (CMV) is a ubiquitous beta-herpes virus that infects the majority of humans and establishes a state of lifelong latency in host cells. Periodic subclinical reactivations are controlled by a functioning immune system. The immunologically-naive fetus is at risk of congenital CMV disease and its complications, such as hearing loss and neurologic deficits. It is the most common congenital infective cause of sensorineural hearing loss and intellectual disability.[57] Pregnant mothers should wash their hands regularly and thoroughly to prevent primary infection (which is usually asymptomatic).Summary
Maternal infection in pregnancy, particularly early in gestation, may cause spontaneous abortion, fetal death, or a wide spectrum of anatomic and laboratory anomalies (congenital rubella syndrome). In the World Health Organization European Region, rubella incidence declined from 234.9 cases per million population in 2005 to 0.7 cases per million by 2019.[58] Specialty consultation is strongly recommended for pregnant women with exposure to rubella.Summary
A mild, usually self-limited infection when symptomatic (about 20% of infections) caused by the Zika virus. Characteristic clinical findings include fever, an itchy maculopapular (sometimes morbilliform) rash, arthralgia, and nonpurulent conjunctivitis.[59] No differences in clinical presentation have been described between pregnant women and nonpregnant patients. Data from the US Zika Pregnancy and Infant Registry found that among pregnancies with confirmed infection, the frequency of any Zika-associated birth defect was higher among those with first (8%) and second (6%) trimester infections compared with third trimester infections (3.8%).[60]Summary
It is recommended that all pregnant women be tested for HIV infection as early as possible in pregnancy.[65] All pregnant women with HIV should receive antiretroviral therapy (ART), as early as possible in the pregnancy, regardless of CD4 count or viral load. Approximately 1.3 million (range 1 to 1.6 million) women with HIV worldwide were pregnant in 2021, of whom an estimated 81% received ART.[66] Untreated, the risk of perinatal transmission of HIV is between 15% and 45%, but can be lowered to 1% or less with a combination of preventative measures including ART for mothers and prophylaxis for neonates.[67]Summary
Group B streptococci (GBS), also known as Streptococcus agalactiae, are gram-positive bacteria that normally colonize the gastrointestinal tract, perineum, and vagina.[68] They can cause invasive infections at any age but infections are most common in the neonatal period, in older people, and in adults with predisposing factors (i.e., pregnancy, diabetes mellitus, immunocompromised).[68] Approximately 10% to 30% of pregnant women are colonized with GBS in the rectum or vagina; in the absence of intervention, around 1% to 2% of babies born to colonized mothers will develop early-onset GBS infection.[69] GBS can produce a wide range of manifestations in pregnant women, including UTI, chorioamnionitis, sepsis, postpartum endometritis, and postpartum wound infection.Summary
Intrahepatic cholestasis of pregnancy (ICP) is a disorder characterized by maternal pruritus (itch) and liver dysfunction, in the absence of other contributing liver disorders and restricted to pregnancy. Risk factors include previous or family history of ICP, cholelithiasis, and history of hepatitis C.[70] [71] [72] [73] The condition likely occurs because of the interplay of reproductive hormones with environmental factors in genetically susceptible individuals. Maternal complications include an increased risk of gestational diabetes mellitus and preeclampsia, in addition to impaired glucose tolerance and dyslipidemia; fetal complications include preterm birth, meconium-staining of the amniotic fluid, neonatal unit admission, and, in pregnant women with bile acid concentrations of ≥100 micromol/L, intrauterine fetal death (stillbirth).[74]Summary
A disorder of pregnancy associated with new-onset hypertension (defined as a systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg), which occurs most often after 20 weeks of gestation and frequently near term. Although often accompanied by new-onset proteinuria, hypertension and other signs or symptoms of preeclampsia may present in some women in the absence of proteinuria.[75] While the exact incidence is unknown, preeclampsia has been reported to occur in about 4% of all pregnancies in the US.[76] When figures include women who develop preeclampsia postpartum, the incidence is between 2% and 8% of all pregnancies worldwide.[77] The woman may be asymptomatic and diagnosed at a routine clinic visit, or she may present acutely with headache, upper abdominal pain, visual disturbances, breathlessness, seizures, and oliguria.Summary
A severe form of preeclampsia characterized by hemolysis (H), elevated liver enzymes (EL), and low platelets (LP) in a pregnant or puerperal woman (usually within 7 days of delivery). HELLP syndrome occurs in approximately 1 to 8 per 1000 pregnancies.[78] The diagnosis of HELLP syndrome should be considered in any pregnant woman presenting in the second half of gestation or immediately postpartum with significant new-onset epigastric/right upper quadrant pain until proven otherwise. Associated with progressive and sometimes rapid maternal and fetal deterioration.Summary
Premature separation of the normally located placenta before delivery of the fetus.[79] May be concealed or overt.[79] Associated with increased perinatal mortality and morbidity. Also a cause of significant maternal morbidity. Placental abruption complicates about 0.3% to 1% of births.[80] [81] Placental abruption may result from direct abdominal trauma, indirect trauma, or cocaine use. Risk factors include smoking, trauma, hypertensive disorders, and cocaine use.Summary
Preterm birth occurs between 24 and 37 weeks' gestation. In two-thirds of cases, it occurs following spontaneous onset of labor. Only 1% of all births occur below 32 weeks' gestation. Mortality and serious morbidity are uncommon above 32 weeks' gestation, although more subtle long-term effects, such as behavioral problems during childhood, still occur with later gestations. Premature labor has a multifactorial etiology, and it is now viewed as a syndrome. Its causal factors can be generally categorized into maternal or fetal. Only a minority of women who present with preterm contractions known as threatened preterm labor progress to actual labor and delivery. The remainder of preterm birth is due to iatrogenic delivery, most commonly because of preeclampsia and intrauterine growth restriction.Summary
Breech presentation in pregnancy occurs when a baby presents with the buttocks or feet rather than the head first (cephalic presentation) and is associated with increased morbidity and mortality for both the mother and the baby.[82] [83] It is common in early pregnancy and decreases with advancing gestational age, as most babies turn spontaneously to a cephalic presentation before birth.[84] [85] Factors that predispose pregnancies to breech presentation include preterm delivery, small for gestational age fetus, primiparity, congenital anomalies in the fetus, abnormal amniotic fluid volume, placental and uterine anomalies, and previous breech delivery.[86] [87] [88] [89] [90]Summary
Rhesus (Rh) incompatibility is a condition where a Rh-negative mother carrying a Rh-positive fetus can produce antibodies against paternally-derived Rh antigens on fetal red blood cells. These antibodies can cross the placenta, and destroy fetal red blood cells. The estimated global prevalence of Rh hemolytic disease is 276/100,000 live births; in countries with well-established perinatal-neonatal care, the prevalence is approximately 2.5/100,000 live births.[91] It is a leading cause of hemolytic disease of the fetus and newborn, also known as erythroblastosis fetalis, which involves progressive fetal anemia and, if untreated, may ultimately lead to hydrops fetalis and death.[92] [93]Summary
An infant born before 37 completed weeks of gestation. In addition to immediate postbirth resuscitation, efforts to reduce excessive oxygen exposure, hyperventilation, hypothermia, and hypoglycemia must be made. Prematurity is common, accounting for 10.6% of live births globally.[94] Consultation with a neonatologist as soon as possible is recommended to reduce potential morbidity.Summary
The development of a depressive illness following childbirth may form part of a bipolar or, more usually, a unipolar illness.[95] Postpartum depression is not recognized by current classification systems as a condition in its own right, but the onset of a depressive episode within 4 weeks of childbirth can be recorded via the peripartum-onset specifier in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, text revision (DSM-5-TR).[96] There is evidence to suggest that the DSM-5-TR specifier is too narrow.[97] Hence, in common usage, depressive episodes occurring within 6 to 12 months of delivery may be considered to be postpartum depression. Studies report a wide range in the prevalence of postpartum depression worldwide, ranging from 0% to 60%.[98] Strong risk factors include history of depression or anxiety, recent stressful life events, violence and abuse, poor social support, preterm and low birth weight infants, and discontinuing psychopharmacologic treatments.[99] [100]
Citations
1. Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 189: nausea and vomiting of pregnancy. Obstet Gynecol. 2018 Jan;131(1):e15-30.[Abstract]
2. Goh YI, Koren G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol. 2008 Jan;28(1):3-13.[Abstract][Full Text]
3. Beaudin AE, Stover PJ. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res A Clin Mol Teratol. 2009 Apr;85(4):274-84.[Abstract][Full Text]
4. Ramakrishnan U, Grant F, Goldenberg T, et al. Effect of women's nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review. Paediatr Perinat Epidemiol. 2012 Jul;26 Suppl 1:285-301.[Abstract][Full Text]
5. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011 [internet publication]. [Full Text]
6. FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine. Good clinical practice advice: iron deficiency anemia in pregnancy. Int J Gynaecol Obstet. 2019 Mar;144(3):322-4.[Abstract][Full Text]
7. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000 Jul;72(1 suppl):257S-64S.[Abstract][Full Text]
8. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998 Apr 3;47(RR-3):1-29.[Abstract]
9. World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. 2nd edition. 2017 [internet publication].[Full Text]
10. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000 Oct;14(5):839-54.[Abstract]
11. Moore J, Shillito TJ, Walker JJ. Current issues in management of miscarriage and early pregnancy bleeding. Hosp Med. 2002 Mar;63(3):134-5.[Abstract]
12. Makrydimas G, Sebire NJ, Lolis D, et al. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound Obstet Gynecol. 2003 Oct;22(4):368-72.[Abstract][Full Text]
13. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol. 2007 Jun 15;165(12):1380-8.[Abstract][Full Text]
14. Ellish NJ, Saboda K, O'Connor J, et al. A prospective study of early pregnancy loss. Hum Reprod. 1996 Feb;11(2):406-12.[Abstract]
15. Quenby SM, Farquharson RG. Predicting recurring miscarriage: what is important? Obstet Gynecol. 1993 Jul;82(1):132-8.[Abstract]
16. Habayeb OM, Konje JC. The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome. Hum Reprod. 2004 Dec;19(12):2952-8.[Abstract][Full Text]
17. Bouyer J, Coste J, Fernandez H, et al. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002 Dec;17(12):3224-30.[Abstract][Full Text]
18. Ankum WM, Mol BW, Van Der Veen F, et al. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril. 1996 Jun;65(6):1093-9.[Abstract]
19. Bakken IJ, Skjeldestad FE. [Incidence and treatment of extrauterine pregnancies in Norway 1990-2001]. [in nor]. Tidsskr Nor Laegeforen. 2003 Nov 6;123(21):3016-20.[Abstract][Full Text]
20. Royal College of Obstetricians and Gynaecologists. Ectopic pregnancy. Nov 2016 [internet publication].[Full Text]
21. Boufous S, Quartararo M, Mohsin M, et al. Trends in the incidence of ectopic pregnancy in New South Wales between 1990-1998. Aust N Z J Obstet Gynaecol. 2001 Nov;41(4):436-8.[Abstract]
22. Mann LM, Kreisel K, Llata E, et al. Trends in ectopic pregnancy diagnoses in United States Emergency Departments, 2006-2013. Matern Child Health J. 2020 Feb;24(2):213-21.[Abstract][Full Text]
23. Getahun D, Oyelese Y, Salihu HM, et al. Previous cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol. 2006 Apr;107(4):771-8.[Abstract]
24. Loto O, Onile TG. Placenta praevia at the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife. A ten year analysis. Niger J Clin Pract. 2008 Jun;11(2):130-3.[Abstract]
25. Yang Q, Wu Wen S, Caughey S, et al. Placenta previa: its relationship with race and the country of origin among Asian women. Acta Obstet Gynecol Scand. 2008;87(6):612-6.[Abstract][Full Text]
26. Sakornbut E, Leeman L, Fontaine P. Late pregnancy bleeding. Am Fam Physician. 2007 Apr 15;75(8):1199-206.[Abstract][Full Text]
27. Magann EF, Cummings JE, Niederhauser A, et al. Antepartum bleeding of unknown origin in the second half of pregnancy: a review. Obstet Gynecol Surv. 2005 Nov;60(11):741-5.[Abstract]
28. American College of Radiology. ACR appropriateness criteria: second and third trimester vaginal bleeding. 2020 [internet publication]. [Full Text]
29. Altman AD, Bentley B, Murray S, et al. Maternal age-related rates of gestational trophoblastic disease. Obstet Gynecol. 2008 Aug;112(2 Pt 1):244-50.[Abstract]
30. Di Cintio E, Parazzini F, Rosa C, et al. The epidemiology of gestational trophoblastic disease. Gen Diagn Pathol. 1997 Nov;143(2-3):103-8.[Abstract]
31. Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222. Obstet Gynecol. 2020 Jun;135(6):1492-5.[Abstract]
32. Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018 Jul;13:291-310.[Abstract]
33. Forrester KJ, Barton JR, O'Brien JM, et al. The effect of gestational hypertension and gestational diabetes on neonatal outcome. Obstet Gynecol. 2006;107:S26.
34. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010 Mar;33(3):676-82.[Full Text]
35. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline. Diabetes Res Clin Pract. 2014 Mar;103(3):341-63.[Full Text]
36. International Diabetes Federation. IDF diabetes atlas 2021. 2021 [internet publication].[Full Text]
37. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997 Oct 1;278(13):1078-83.[Abstract]
38. Lo JC, Feigenbaum SL, Escobar GJ, et al. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care. 2006 Aug;29(8):1915-7.[Abstract][Full Text]
39. Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007 Aug 25;370(9588):685-97.[Abstract]
40. Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007 Dec 12;298(22):2654-64.[Abstract]
41. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab. 2004 Jun;89(6):2590-4.[Abstract]
42. Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care. 2007 May;30(5):1314-9.[Abstract][Full Text]
43. Plows JF, Stanley JL, Baker PN, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018 Oct 26;19(11)[Abstract][Full Text]
44. Cremona A, O'Gorman C, Cotter A, et al. Effect of exercise modality on markers of insulin sensitivity and blood glucose control in pregnancies complicated with gestational diabetes mellitus: a systematic review. Obes Sci Pract. 2018 Oct;4(5):455-67.[Abstract][Full Text]
45. Davenport MH, Ruchat SM, Poitras VJ, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br J Sports Med. 2018 Nov;52(21):1367-75.[Abstract][Full Text]
46. Egan ME, Lipsky MS. Diagnosis of vaginitis. Am Fam Physician. 2000 Sep 1;62(5):1095-104.[Abstract][Full Text]
47. Svare JA, Schmidt H, Hansen BB, et al. Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG. 2006 Dec;113(12):1419-25.[Abstract]
48. McGregor JA, French JI, Parker R, et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol. 1995 Jul;173(1):157-67.[Abstract]
49. Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore). 1998 Sep;77(5):313-36.[Abstract][Full Text]
50. Mylonakis E, Paliou M, Hohmann EL, et al. Listeriosis during pregnancy: a case series and review of 222 cases. Medicine (Baltimore). 2002 Jul;81(4):260-9.[Full Text]
51. Schwartz B, Hexter D, Broome CV, et al. Investigation of an outbreak of listeriosis: new hypotheses for the etiology of epidemic Listeria monocytogenes infections. J Infect Dis. 1989 Apr;159(4):680-5.[Abstract]
52. Pinner RW, Schuchat A, Swaminathan B, et al. Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA. 1992 Apr 15;267(15):2046-50.[Abstract]
53. Ascher NL, Simmons RL, Marker S, et al. Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg. 1978 Jan;113(1):90-4.[Abstract]
54. Berenguer J, Solera J, Diaz MD, et al. Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis. 1991 Jan-Feb;13(1):115-9.[Abstract]
55. Nogareda F, Le Strat Y, Villena I, et al. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation. Epidemiol Infect. 2014 Aug;142(8):1661-70.[Abstract][Full Text]
56. Wilson CB, Remington JS, Stagno S, et al. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767-74.[Abstract]
57. Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol. 2004 Feb;29(2):71-83.[Abstract]
58. O'Connor P, Jankovic D, Zimmerman L, et al. Progress toward rubella elimination - World Health Organization European Region, 2005-2019. MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):833-9.[Abstract][Full Text]
59. Pan American Health Organization; World Health Organization. Provisional remarks on Zika virus infection in pregnant women: document for health care professionals. January 2016 [internet publication].[Full Text]
60. Roth NM, Reynolds MR, Lewis EL, et al. Zika-associated birth defects reported in pregnancies with laboratory evidence of confirmed or possible Zika virus infection - U.S. Zika Pregnancy and Infant Registry, December 1, 2015-March 31, 2018. MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(3):73-9.[Abstract][Full Text]
61. Russell K, Oliver SE, Lewis L,et al. Update: Interim guidance for the evaluation and management of infants with possible congenital Zika virus infection - United States, August 2016. MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):870-8.[Abstract][Full Text]
62. Moore CA, Staples JE, Dobyns WB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr. 2017 Mar 1;171(3):288-95.[Abstract]
63. Melo AS, Aguiar RS, Amorim MM, et al. Congenital Zika virus infection: beyond neonatal microcephaly. JAMA Neurol. 2016 Dec 1;73(12):1407-16. [Abstract][Full Text]
64. França GV, Schuler-Faccini L, Oliveira WK, et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet. 2016 Aug 27;388(10047):891-7.[Abstract][Full Text]
65. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.[Abstract][Full Text]
66. World Health Organization. Data on the HIV response. 2024 [internet publication].[Full Text]
67. Joint United Nations Programme on HIV/Aids (UNAIDS). WHO validates elimination of mother-to-child transmission of HIV and syphilis in Cuba. Jun 2015 [internet publication].[Full Text]
68. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Elsevier; 2019.[Full Text]
69. Prevention of group B streptococcal early-onset disease in newborns: ACOG committee opinion summary, number 797. Obstet Gynecol. 2020 Feb;135(2):489-92.[Abstract][Full Text]
70. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004 Aug;40(2):467-74.[Abstract]
71. Turunen K, Helander K, Mattila KJ, et al. Intrahepatic cholestasis of pregnancy is common among patients' first-degree relatives. Acta Obstet Gynecol Scand. 2013 Sep;92(9):1108-10.[Abstract][Full Text]
72. Marschall HU, Wikström Shemer E, Ludvigsson JF, et al. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology. 2013 Oct;58(4):1385-91.[Abstract][Full Text]
73. Wijarnpreecha K, Thongprayoon C, Sanguankeo A, et al. Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):39-45.[Abstract]
74. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019 Mar 2;393(10174):899-909.[Abstract][Full Text]
75. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019 Jan;133(1):1.[Abstract][Full Text]
76. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for preeclampsia: US Preventive Services Task Force Recommendation Statement. JAMA. 2017 Apr 25;317(16):1661-7.[Abstract]
77. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013 Oct;71 Suppl 1(0 1):S18-25.[Abstract][Full Text]
78. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009 Feb 26;9:8.[Abstract][Full Text]
79. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006 Oct;108(4):1005-16.[Abstract]
80. Ananth CV, Keyes KM, Hamilton A, et al. An international contrast of rates of placental abruption: an age-period-cohort analysis. PLoS One. 2015;10(5):e0125246.[Abstract][Full Text]
81. Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011 Feb;90(2):140-9.[Abstract][Full Text]
82. Cunningham FG, Leveno K, Dashe J et al. Williams Obstetrics. 26th ed. New York (NY): McGraw-Hill Education; 2022.[Full Text]
83. Decherney AH, Roman AS, Nathan L et al. Current Diagnosis & Treatment Obstetrics & Gynecology. 12th ed. New York (NY): McGraw-Hill Education/Medical; 2018.[Full Text]
84. Scheer K, Nubar J. Variation of fetal presentation with gestational age. Am J Obstet Gynecol. 1976 May 15;125(2):269-70.[Abstract][Full Text]
85. Nassar N, Roberts CL, Cameron CA, et al. Diagnostic accuracy of clinical examination for detection of non-cephalic presentation in late pregnancy: cross sectional analytic study. BMJ. 2006 Sep 16;333(7568):578-80.[Abstract][Full Text]
86. Roberts CL, Peat B, Algert CS, et al. Term breech birth in New South Wales, 1990-1997. Aust N Z J Obstet Gynaecol. 2000 Feb;40(1):23-9.[Abstract]
87. Roberts CL, Algert CS, Peat B, et al. Small fetal size: a risk factor for breech birth at term. Int J Gynaecol Obstet. 1999 Oct;67(1):1-8.[Abstract]
88. Brar HS, Platt LD, DeVore GR, et al. Fetal umbilical velocimetry for the surveillance of pregnancies complicated by placenta previa. J Reprod Med. 1988 Sep;33(9):741-4.[Abstract]
89. Kian LS. The role of the placental site in the aetiology of Breech presentation; a clinical survey of 362 cases. J Obstet Gynaecol Br Commonw. 1963 Oct;70:795-7.[Abstract]
90. Rayl J, Gibson PJ, Hickok DE. A population-based case-control study of risk factors for breech presentation. Am J Obstet Gynecol. 1996 Jan;174(1 pt 1):28-32.[Abstract]
91. Bhutani VK, Zipursky A, Blencowe H, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013 Dec;74 Suppl 1(suppl 1):86-100.[Abstract][Full Text]
92. Hadley AG. In vitro assays to predict the severity of hemolytic disease of the newborn. Transfus Med Rev. 1995 Oct;9(4):302-13.[Abstract]
93. Brennand J, Cameron A. Fetal anaemia: diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2008 Feb;22(1):15-29.[Abstract]
94. Chawanpaiboon S, Vogel JP, Moller AB, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019 Jan;7(1):e37-46.[Abstract][Full Text]
95. Musters C, McDonald E, Jones I. Management of postnatal depression. BMJ. 2008 Aug 8;337:a736.[Abstract][Full Text]
96. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
97. Forty L, Jones L, Macgregor S, et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry. 2006 Sep;163(9):1549-53.[Abstract]
98. Halbreich U, Karkun S. Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms. J Affect Disord. 2006 Apr;91(2-3):97-111.[Abstract]
99. Zhao XH, Zhang ZH. Risk factors for postpartum depression: an evidence-based systematic review of systematic reviews and meta-analyses. Asian J Psychiatr. 2020 Oct;53:102353.[Abstract]
100. Guintivano J, Manuck T, Meltzer-Brody S. Predictors of postpartum depression: a comprehensive review of the last decade of evidence. Clin Obstet Gynecol. 2018 Sep;61(3):591-603.[Abstract][Full Text]
Referenced Articles
Sign in to access our clinical decision support tools